(Q46909756)

English

Study on the safety and efficacy of tocilizumab, an anti-IL-6 receptor antibody, in patients with rheumatoid arthritis complicated with AA amyloidosis

scientific article published on 21 October 2013

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/24252016

Study on the safety and efficacy of tocilizumab, an anti-IL-6 receptor antibody, in patients with rheumatoid arthritis complicated with AA amyloidosis (English)

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/24252016

1 reference

based on heuristic

inferred from title

rheumatoid arthritis

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Kazuyoshi Saito

3

object named as

Kazuyoshi Saito

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/24252016

author name string

Ippei Miyagawa

1

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/24252016

Shingo Nakayamada

2

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/24252016

Kentaro Hanami

4

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/24252016

Masao Nawata

5

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/24252016

Norifumi Sawamukai

6

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/24252016

Kazuhisa Nakano

7

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/24252016

Kunihiro Yamaoka

8

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/24252016

Yoshiya Tanaka

9

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/24252016

publication date

21 October 2013

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/24252016

Modern Rheumatology

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/24252016

24

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/24252016

3

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/24252016

405-409

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/24252016

More evidence of declining incidence of amyloidosis associated with inflammatory rheumatic diseases

1 reference

https://api.crossref.org/works/10.3109%2F14397595.2013.844294

21 January 2018

Natural history and outcome in systemic AA amyloidosis

1 reference

https://api.crossref.org/works/10.3109%2F14397595.2013.844294

21 January 2018

Amyloid load and clinical outcome in AA amyloidosis in relation to circulating concentration of serum amyloid A protein

1 reference

https://api.crossref.org/works/10.3109%2F14397595.2013.844294

21 January 2018

Treatment of renal amyloidosis with etanercept in tumour necrosis factor receptor-associated periodic syndrome

1 reference

https://api.crossref.org/works/10.3109%2F14397595.2013.844294

21 January 2018

A case of AA amyloidosis associated with rheumatoid arthritis effectively treated with Infliximab

1 reference

https://api.crossref.org/works/10.3109%2F14397595.2013.844294

21 January 2018

Effective anti-TNF-alpha therapy can induce rapid resolution and sustained decrease of gastroduodenal mucosal amyloid deposits in reactive amyloidosis associated with rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.3109%2F14397595.2013.844294

21 January 2018

Etanercept can induce resolution of renal deterioration in patients with amyloid A amyloidosis secondary to rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.3109%2F14397595.2013.844294

21 January 2018

Study of active controlled monotherapy used for rheumatoid arthritis, an IL-6 inhibitor (SAMURAI): evidence of clinical and radiographic benefit from an x ray reader-blinded randomised controlled trial of tocilizumab

1 reference

https://api.crossref.org/works/10.3109%2F14397595.2013.844294

21 January 2018

Treatment of rheumatoid arthritis with humanized anti-interleukin-6 receptor antibody: a multicenter, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.3109%2F14397595.2013.844294

21 January 2018

Interleukin 6: from bench to bedside

1 reference

https://api.crossref.org/works/10.3109%2F14397595.2013.844294

21 January 2018

Tocilizumab dramatically ameliorated life-threatening diarrhea due to secondary amyloidosis associated with rheumatoid arthritis.

1 reference

https://api.crossref.org/works/10.3109%2F14397595.2013.844294

21 January 2018

Excellent therapeutic effect of tocilizumab on intestinal amyloid a deposition secondary to active rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.3109%2F14397595.2013.844294

21 January 2018

The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.3109%2F14397595.2013.844294

21 January 2018

Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO).

1 reference

https://api.crossref.org/works/10.3109%2F14397595.2013.844294

21 January 2018

Essential role of STAT3 in cytokine-driven NF-kappaB-mediated serum amyloid A gene expression.

1 reference

https://api.crossref.org/works/10.3109%2F14397595.2013.844294

21 January 2018

Expression and function of serum amyloid A, a major acute-phase protein, in normal and disease states

1 reference

https://api.crossref.org/works/10.3109%2F14397595.2013.844294

21 January 2018

Susceptibility to AA amyloidosis in rheumatic diseases: a critical overview

1 reference

https://api.crossref.org/works/10.3109%2F14397595.2013.844294

21 January 2018

IL-6 plays a critical role in the synergistic induction of human serum amyloid A (SAA) gene when stimulated with proinflammatory cytokines as analyzed with an SAA isoform real-time quantitative RT-PCR assay system

1 reference

https://api.crossref.org/works/10.3109%2F14397595.2013.844294

21 January 2018

Rapid and complete resolution of proteinuria due to renal amyloidosis in a patient with rheumatoid arthritis treated with infliximab

1 reference

https://api.crossref.org/works/10.3109%2F14397595.2013.844294

21 January 2018

Identifiers

10.3109/14397595.2013.844294

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/24252016

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/24252016

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46909756&oldid=2137588134"